Princeton Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Princeton Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-450	Closed	-$43K	–	95
2022 Q3	$43K	Hold	450	–	–	0.02%	89
2022 Q2	$88K	Sell	450 -16	-3%	-$2.61K	0.03%	94
2022 Q1	$108K	Hold	466	–	–	0.03%	108
2021 Q4	$184K	Sell	466 -18	-4%	-$7.58K	0.05%	111
2021 Q3	$216K	Buy	484 +19	+4%	+$6.81K	0.07%	104
2021 Q2	$181K	Buy	465 +24	+5%	+$8.56K	0.06%	105
2021 Q1	$158K	Hold	441	–	–	0.05%	100
2020 Q4	$216K	Sell	441 -102	-19%	-$47.1K	0.08%	98
2020 Q3	$176K	Hold	543	–	–	0.07%	92
2020 Q2	$198K	Buy	+543	New	+$137K	0.09%	91
2019 Q4	–	Sell	-181	Closed	-$64K	–	102
2019 Q3	$64K	Buy	181 +88	+95%	+$32.8K	0.03%	139
2019 Q2	$47K	Buy	+93	New	+$65.6K	0.02%	154

Other funds holding ATRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return